Amoroso v. Sun Life Assurance Company of Canada

CourtDistrict Court, W.D. Washington
DecidedSeptember 2, 2021
Docket3:20-cv-05887
StatusUnknown

This text of Amoroso v. Sun Life Assurance Company of Canada (Amoroso v. Sun Life Assurance Company of Canada) is published on Counsel Stack Legal Research, covering District Court, W.D. Washington primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Amoroso v. Sun Life Assurance Company of Canada, (W.D. Wash. 2021).

Opinion

1 2 3

5 UNITED STATES DISTRICT COURT 6 WESTERN DISTRICT OF WASHINGTON AT TACOMA 7 PAUL AMOROSO, CASE NO. C20-5887 BHS 8 Plaintiff, ORDER ON RULE 52 CROSS- 9 v. MOTIONS FOR JUDGMENT 10 SUN LIFE ASSURANCE COMPANY OF CANADA, 11 Defendant. 12

13 THIS MATTER is before the Court on Plaintiff Paul Amoroso’s Rule 52 motion 14 for judgment, Dkt. 18, and Defendant Sun Life Assurance Company of Canada’s cross- 15 motion for judgment, Dkt. 19. The Court has considered the filings and the record. Its 16 rulings follow. 17 I. BACKGROUND 18 Amoroso was employed as a Physician Executive with MultiCare Health System, 19 overseeing a large group of medical researchers. He suffers from mental health 20 conditions including depression, anxiety, and attention and task-completion disorders. 21 Neuropsychological examinations in 2009 and 2010 “revealed deficits consistent with 22 1 attention deficit disorder.” Dkt. 18 at 4 (citing AR 855–60, 869–71). From 2011 through 2 2016, Amoroso was employed as a Medical Director at MultiCare and transitioned to his 3 role as a Physician Executive in 2016. Dkt. 20 at AR 746.

4 In 2017, Amoroso told his psychiatrist, Dr. Tim Earnest, that he was concerned he 5 was not functioning as well as needed at work, but that he has had good reviews and 6 “others feel he is performing sufficiently.” AR 1649. In mid-2018, Amoroso experienced 7 anxiety and depression based on the impact his focus-based symptoms were having on 8 his work performance and sought treatment. AR 1865.

9 Amoroso took partial leave under the Family Medical Leave Act (“FMLA”), 10 beginning December 14, 2018 and ending 80 days later on March 4, 2019. On his 11 reduced schedule, he worked four days per week, using a combination of paid time off 12 and unpaid leave under the FMLA for the fifth day. As a result, Amoroso did not earn 13 less than 80% of his pay during his reduced work schedule. He saw some improvement in

14 his symptoms in the context of his reduced work responsibilities. AR 1831–42. 15 Amoroso initially applied for 90 days of FMLA leave but returned to full time 16 work after 80 days. He worked full time from March 4, 2019 through April 26, 2019, 17 when Amoroso resigned from his job. He had announced his resignation prior to his 18 departure from work and discussed with his psychiatrist, Dr. George Jackson, that in

19 anticipation of leaving his job, he had a corresponding improvement in symptoms. AR 20 1141. After his resignation, Amoroso told Earnest that he left work due to concerns about 21 his effectiveness, but that his supervisor did not share those concerns. AR 1433. 22 1 After his resigned, Amoroso underwent a neuropsychological consultation with 2 Glen T. Goodwin, PhD. AR 270–87. Dr. Goodwin found that 3 On neurocognitive testing, within the context of very superior general ability and very superior verbal comprehension, there are clearly areas of 4 deficit seen on a task of divided attention, freedom from interference (response inhibition) and dependent on processing speed. There are also 5 deficits seen on a task of complex sequencing, involving multitasking with two notions simultaneously. In a broader sense, he displays clinically 6 significant weaknesses in auditory working memory and processing speed relative to his verbal comprehension. There [are] also clinically significant 7 weaknesses evident in visual working memory, visual memory, immediate memory and delayed memory relative to his general ability. There also 8 appears to be a decline evident on a task of reasoning, problem solving and concept formation (although this would need to be corroborated with actual 9 comparison of the previous raw test data.

10 AR 1976. Goodwin concluded: 11 I would estimate that he is not work tolerant from a neuropsychological standpoint in any similar competitive employment situation at this time. For 12 a physician, even involved in doing research, there is little room for error and given his pattern of neuropsychological symptomatology and the 13 evidence on objective neurocognitive and neurobehavioral testing, I can certainly appreciate why he resigned himself to the decision to cease his 14 employment.

15 AR 1977. 16 Amoroso sought long-term disability benefits from MultiCare’s group disability 17 insurer, Sun Life, in July 2019, claiming a disability onset date of December 14, 2018 18 (the date he first took FMLA leave). AR 744. As part of its investigation, a Sun Life 19 representative interviewed Amoroso. The summary of interview reported: 20 [Amoroso] took 90 days of family medical leave with plans to return with certain restrictions. He was on track to return in a more part-time capacity 21 with no management responsibilities; however, he spoke with some of his colleagues, who, he stated, had some resentment toward him about his 22 1 leave. He decided it was not a good environment for him to return to and he resigned. 2 AR 300. Sun Life also had Dr. Margaret O’Connor also review Amoroso’s claim. She 3 concluded that, while his records show attention problems for many years, including 4 during medical school, and an “[u]pdated assessment and raw data from Dr. Goodwin 5 continues to suggest attention problems,” “there is no evidence of significant cognitive 6 impairment in any area.” AR 1103. 7 Sun Life denied benefits, concluding that Amoroso had not established disability 8 throughout the policy’s 90-day Elimination Period. AR 1355–63. Amoroso appealed, 9 providing recent medical records and a vocational evaluation. AR 1993–2051; AR 1397– 10 1455. Reviewing neuropsychologist David A. Miller, PhD, determined that Amoroso’s 11 records did not support restrictions or limitations preventing him from functioning 12 effectively as an executive physician. AR 1510. Specific to Dr. Goodwin’s conclusions, 13 Dr. Miller reasoned that 14 [I]t is unwarranted to assume that all of [Amoroso’s] abilities must be 15 commensurate with his strengths in order for him to function adequately in his chosen occupation. Indeed, the most compelling evidence of his ability 16 to perform adequately in his chosen occupation is his satisfactory performance in it since 2011. 17 AR 1514. 18 Amoroso sued, seeking long term benefits under the Sun Life policy, on the 19 Administrative Record of his claim to Sun Life. His complaint alleges he became 20 disabled on April 26, 2019, the day he resigned. Dkt. 1. 21

22 1 II. DISCUSSION 2 A. Standard of Review 3 The parties agree that the Court reviews this denial of long-term disability benefits

4 under ERISA de novo. See Abatie v. Alta Health & Life Ins. Co., 458 F.3d 955, 963 (9th 5 Cir. 2006) (citations omitted) (denial of benefits is reviewed de novo when a plan does 6 not confer discretion on the administrator to determine eligibility or construe the terms of 7 a plan). Under de novo review, “the court simply proceeds to evaluate whether the plan 8 administrator correctly or incorrectly denied benefits.” Id.

9 The claimant has the burden of proof, Muniz v. Amec Constr. Mgmt., Inc., 623 10 F.3d 1290, 1294 (9th Cir. 2010), and the court makes findings of fact and weighs 11 evidence, Walker v. Am. Home Shield Long Term Disability Plan, 180 F.3d 1065, 1069 12 (9th Cir. 1999), in contrast to a summary judgment decision. Generally, “only the 13 evidence that was before the plan administrator at the time of determination should be

14 considered.” Opeta v. Nw. Airlines Pension Plan for Cont. Emps., 484 F.3d 1211, 1217 15 (9th Cir. 2007) (citing Mongeluzo v.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Amoroso v. Sun Life Assurance Company of Canada, Counsel Stack Legal Research, https://law.counselstack.com/opinion/amoroso-v-sun-life-assurance-company-of-canada-wawd-2021.